Therapeutic effect of methotrexate combined with electroacupuncture in rheumatoid arthritis rats

doi:10.3969/j.issn.2095-4344.2816

Abstract

Abstract:

BACKGROUND: Currently, methotrexate for rheumatoid arthritis has been explored; however, there are still some problems such as unsatisfactory treatment effects.

OBJECTIVE: To investigate the therapeutic effect and mechanism of methotrexate combined with electroacupuncture in rheumatoid arthritis rats.

METHODS: A total of 100 Wistar rats were selected, 80 of which were injected type II collagenase to induce rheumatoid arthritis models. After successful modeling, the model rats were randomly divided into model group, methotrexate group, electroacupuncture group, and methotrexate+electroacupuncture group. The remaining 20 normal animals untreated were used as the normal control group. The arthritis index was evaluated at 1, 6, and 12 weeks of treatment. Hematological changes in the ankle were observed with hematoxylin-eosin staining at 12 weeks after treatment. RT-PCR and western blot were used to detect changes in tumor necrosis factor α, JAK3, and STAT3 expression levels. Flow cytometry was used to detect the apoptotic rate of chondrocytes.

RESULTS AND CONCLUSION: Compared with the model group, methotrexate and electroacupuncture alone or in combination could significantly reduce the arthritis index of rheumatoid arthritis rats at 1, 6, and 12 weeks after administration (P < 0.05), and the reduction tendency was more significant in the methotrexate+electroacupuncture group. There was no synovial tissue lesion and joint capsule hyperplasia in the normal control group. In the model group, synovial tissue was infiltrated by extensive inflammatory cells; vasodilation and vascular hyperplasia in the synovium triggered the formation of vascular pannus; and intrathecal ligament nerve injury and proliferation of synovial and fibrous tissues were observed. Histological changes in the synovium were less after treatment with methotrexate and electroacupuncture alone than in combination. Treatment with methotrexate plus electroacupuncture obviously decreased inflammatory cell infiltration and synovial hyperplasia. Compared with the model group, the levels of tumor necrosis factor-α, JAK3 and STAT3 mRNA and protein were significantly reduced in the methotrexate group, electroacupuncture group, and methotrexate+electroacupuncture group (P < 0.05), and the reduction was more significant in the methotrexate+electroacupuncture group (P < 0.05). The apoptotic rate of chondrocytes was highest in the model group, followed by the methotrexate group, electroacupuncture group, and methotrexate+electroacupuncture group (P < 0.05). However, the apoptotic rate of chondrocytes in the methotrexate+electroacupuncture group was still higher than that in the normal control group (P < 0.05). To conclude, the combination of methotrexate and electroacupuncture for rheumatoid arthritis can inhibit the activity of tumor necrosis factor and JAK-STAT pathways, reduce the apoptosis of chondrocytes, and protect the articular cartilage.

Key words: ">rheumatoid arthritis, methotrexate, electroacupuncture, tumor necrosis factor pathway, JAK-STAT pathway, rat, experiment

CLC Number:

Zhang Guanghui, Zhang Chao, Guo Zhanfei, Hou Xiaodong. Therapeutic effect of methotrexate combined with electroacupuncture in rheumatoid arthritis rats[J]. Chinese Journal of Tissue Engineering Research, 2020, 24(29): 4667-4672.

Figures/Tables 6

References

[1] LIU XZ, GAO Y, ZHU CH, et al. Effect of Dishevelled 2 on apoptosis in rheumatoid arthritis fibroblast-like synoviocytes through inhibiting JAK-STAT pathway. Zhonghua Yi Xue Za Zhi. 2018;98(15):1189-1193.

[2] LIMA A, BERNARDES M, AZEVEDO R, et al. Pharmacogenomics of Methotrexate Membrane Transport Pathway: Can Clinical Response to Methotrexate in Rheumatoid Arthritis Be Predicted? Int J Mol Sci. 2015;16(6): 13760-13780.

[3] PARK JK, CHOI Y, WINTHROP KL, et al. Optimal time between the last methotrexate administration and seasonal influenza vaccination in rheumatoid arthritis: post hoc analysis of a randomised clinical trial. Ann Rheum Dis. 2019;78(9): 1283-1284.

[4] LU L, ZHU J, ZHENG Z, et al. Jak-STAT pathway is involved in the induction of TNF-beta gene during stimulation by IL-2. Eur J Immunol. 1998;28(3):805-810.

[5] KIM H, JEONG H, LEE J, et al. AB0091 Hypoxia Induce Slug Expression via JAK/STAT3 Pathway in Rheumatoid Arthritis Fibroblast-like Synoviocytes. Annals of the Rheumatic Diseases. 2016; 75(2):928.1-928.

[6] THOMAS S, FISHER K, SNOWDEN J, et al. Effect of methotrexate on JAK/STAT pathway activation in myeloproliferative neoplasms. Lancet. 2015;385 Suppl 1:S98.

[7] LI HX, ZHAO W, SHI Y, et al. Retinoic acid amide inhibits JAK/STAT pathway in lung cancer which leads to apoptosis. Tumour Biol. 2015;36(11):8671-8678.

[8] MALEMUD CJ. The role of the JAK/STAT signal pathway in rheumatoid arthritis. Ther Adv Musculoskelet Dis. 2018; 10(5-6):117-127.

[9] 崔毅佳,王淑梅,金志国.甲氨蝶呤通过抑制TLR2-NF-κB信号通路减轻类风湿关节炎大鼠滑膜炎的作用研究[J].新疆医科大学学报, 2019,42(2):77-82.

[10] 王晔.电针联合扶正祛邪方治疗类风湿关节炎疗效及对TNF-α、SIL-2R、CRP的影响[J].现代中西医结合杂志, 2019,28(7): 724-727.

[11] 高燕萍,魏荣锐,吴强,等.无尾果醇提物对类风湿性关节炎大鼠的影响[J].中成药, 2019,41(3):190-193.

[12] CHOE JY, PARK KY, PARK SH, et al. Regulatory effect of calcineurin inhibitor, tacrolimus, on IL-6/sIL-6R-mediated RANKL expression through JAK2-STAT3-SOCS3 signaling pathway in fibroblast-like synoviocytes. Arthritis Res Ther. 2013;15(1):R26.

[13] ZHAI Y, WU B, LI J, et al. CD147 promotes IKK/IκB/NF-κB pathway to resist TNF-induced apoptosis in rheumatoid arthritis synovial fibroblasts. J Mol Med (Berl). 2016;94(1): 71-82.

[14] ZHANG XF, XIANG SY, GENG WY, et al. Electro-acupuncture regulates the cholinergic anti-inflammatory pathway in a rat model of chronic obstructive pulmonary disease. J Integr Med. 2018;16(6):418-426.

[15] TANAKA Y, EMOTO K, TSUJIMOTO M, et al. THU0149 Efficacy and Safety of Baricitinib in Japanese Rheumatoid Arthritis Patients at 12 Weeks. Annals of the Rheumatic Diseases. 2014;73(2):231.

[16] CHEN H, SHAO X, LI L, et al. Electroacupuncture serum inhibits TNF‑α‑mediated chondrocyte inflammation via the Ras‑Raf‑MEK1/2‑ERK1/2 signaling pathway. Mol Med Rep. 2017;16(5):5807-5814.

[17] BOYLE DL, SOMA K, HODGE J, et al. The JAK inhibitor tofacitinib suppresses synovial JAK1-STAT signalling in rheumatoid arthritis. Ann Rheum Dis. 2015;74(6):1311-1316.

[18] TANAKA Y. Recent progress and perspective in JAK inhibitors for rheumatoid arthritis: from bench to bedside. J Biochem. 2015;158(3):173-179.

[19] COFFEY G, BETZ A, GRAF J, et al. Methotrexate and a spleen tyrosine kinase inhibitor cooperate to inhibit responses to peripheral blood B cells in rheumatoid arthritis. Pharmacol Res Perspect. 2013;1(2):e00016.

[20] BLITS M, JANSEN G, ASSARAF YG, et al. Methotrexate normalizes up-regulated folate pathway genes in rheumatoid arthritis. Arthritis Rheum. 2013;65(11):2791-2802.

[21] SATOU A, BANNO S, HANAMURA I, et al. EBV-positive mucocutaneous ulcer arising in rheumatoid arthritis patients treated with methotrexate: Single center series of nine cases. Pathol Int. 2019;69(1):21-28.